DR REDDYS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DR REDDYS, and when can generic versions of DR REDDYS drugs launch?
DR REDDYS has three hundred and seventy-two approved drugs.
There is one US patent protecting DR REDDYS drugs. There are twenty-one tentative approvals on DR REDDYS drugs.
There is one patent family member on DR REDDYS drugs in one country and seven hundred and eighty supplementary protection certificates in eighteen countries.
Summary for DR REDDYS
| International Patents: | 1 |
| US Patents: | 1 |
| Tradenames: | 297 |
| Ingredients: | 270 |
| NDAs: | 372 |
Drugs and US Patents for DR REDDYS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys | TADALAFIL | tadalafil | TABLET;ORAL | 210069-001 | Mar 26, 2019 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys | DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride | INJECTABLE;INJECTION | 080873-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Dr Reddys Labs Sa | CLARITHROMYCIN | clarithromycin | TABLET, EXTENDED RELEASE;ORAL | 065154-001 | May 18, 2005 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys | VALSARTAN | valsartan | TABLET;ORAL | 201618-002 | Oct 5, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 203874-009 | Mar 7, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys | DARUNAVIR | darunavir | TABLET;ORAL | 211578-001 | Nov 28, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys Labs Ltd | OXAPROZIN | oxaprozin | TABLET;ORAL | 075855-001 | Jan 31, 2001 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DR REDDYS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-004 | Nov 12, 1999 | 4,597,961 | ⤷ Sign Up |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-005 | Nov 12, 1999 | 4,597,961 | ⤷ Sign Up |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-005 | Nov 12, 1999 | 5,016,652 | ⤷ Sign Up |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-006 | Nov 12, 1999 | 5,016,652 | ⤷ Sign Up |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-006 | Nov 12, 1999 | 4,597,961 | ⤷ Sign Up |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-006 | Nov 12, 1999 | 5,834,011 | ⤷ Sign Up |
| Dr Reddys Labs Sa | TRI-NORINYL 28-DAY | ethinyl estradiol; norethindrone | TABLET;ORAL-28 | 018977-002 | Apr 13, 1984 | 4,390,531 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for DR REDDYS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for DR REDDYS Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016132270 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for DR REDDYS Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0633893 | 11C0055 | France | ⤷ Sign Up | PRODUCT NAME: ABIRATERONE, SES SELS D'ADDITION D'ACIDE ET 3-ESTERS, EN PARTICULIER ACETATE D'ABIRATERONE; REGISTRATION NO/DATE: EU/1/11/714/001 20110905 |
| 0350733 | C300111 | Netherlands | ⤷ Sign Up | PRODUCT NAME: MOXIFLOXACINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER MOXIFLOXACINEHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 28118 RVG 28119 20021017; FIRST REGISTRATION: DE 45263.00.00 19990621 |
| 1884242 | 132014902294693 | Italy | ⤷ Sign Up | PRODUCT NAME: LURASIDONE, OPZIONALMENTE IN FORMA DI BASE LIBERA O DI SUOI SALI FARMACEUTICAMENTE ACCETTABILI(LATUDA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/913, 20140321 |
| 0751129 | 09C0040 | France | ⤷ Sign Up | PRODUCT NAME: ESLICARBAZEPINE ACETATE; REGISTRATION NO/DATE IN FRANCE: EU/1/09/514/001 DU 20090421; REGISTRATION NO/DATE AT EEC: EU/1/09/514/001 DU 20090421 |
| 1453521 | 122015000093 | Germany | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
| 0619813 | C300425 | Netherlands | ⤷ Sign Up | PRODUCT NAME: PLERIXAFOR, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH ZUURADDITIE ZOUT OF METAALCOMPLEX; REGISTRATION NO/DATE: EU/1/09/537/001 20090731 |
| 1666481 | 17C1031 | France | ⤷ Sign Up | PRODUCT NAME: TOFACITINIB,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,DONT LE CITRATE DE SODIUM; REGISTRATION NO/DATE: EU/1/17/1178 20170324 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
